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Abstract The LIM domain only 4 (LMO4) protein is
expressed in the hypothalamus, but its function there is not
known. Using mice with LMO4 ablated in postnatal
glutamatergic neurons, including most neurons of the
paraventricular (PVN) and ventromedial (VMH) hypotha-
lamic nuclei where LMO4 is expressed, we asked whether
LMO4 is required for metabolic homeostasis. LMO4
mutant mice exhibited early onset adiposity. These mice
had reduced energy expenditure and impaired thermogen-
esis together with reduced sympathetic outﬂow to adipose
tissues. The peptide hormone leptin, produced from adi-
pocytes, activates Jak/Stat3 signaling at the hypothalamus
to control food intake, energy expenditure, and fat metab-
olism. Intracerebroventricular infusion of leptin suppressed
feeding similarly in LMO4 mutant and control mice.
However, leptin-induced fat loss was impaired and acti-
vation of Stat3 in the VMH was blunted in these mice.
Thus, our study identiﬁes LMO4 as a novel modulator of
leptin function in selective hypothalamic nuclei to regulate
fat metabolism.
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Introduction
Obesity is a global pandemic associated with an increased
risk of death from heart disease and stroke. Identifying
genetic modiﬁers that contribute to obesity is therefore of
considerable clinical interest. Discovery of the peptide
hormone leptin [1] has led to a better understanding of the
sophisticated system that regulates metabolism. Leptin is
secreted from adipose tissue in a manner that is directly
proportional to the degree of adiposity [2]. By binding
receptors on neurons of various hypothalamic nuclei, leptin
works in a feedback loop to control food intake, energy
expenditure, and fat stores. Leptin signaling in the arcuate
nucleus (ARC) controls food intake by activating the
anorexic POMC neurons [3], and mice deﬁcient in leptin
receptors are hyperphagic and obese [4]. In addition,
excitatory glutamatergic neurons from the VMH project to
POMC neurons of the ARC to inhibit feeding [5]. In the
VMH, leptin also regulates energy homeostasis and fat
metabolism [6, 7]. Leptin increases sympathetic adrenergic
tone to adipose tissue and promotes lipolysis [8]. Leptin
increases parasympathetic tone that enhances the insulin-
dependent inhibition of gluconeogenesis by the liver [9].
The leptin receptor is a member of the type I cytokine
receptor family including the IL-6 receptors. Leptin binds
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123to its receptor and activates the Janus kinase (Jak) protein
kinase that phosphorylates and engages the signal trans-
ducer and activator of transcription-3 (Stat3) pathway [10].
Activation of Stat3, a transcription factor that modulates
gene expression, is essential for leptin action in the hypo-
thalamus [11]. Factors that modulate Stat3 signaling in the
hypothalamus would be expected to inﬂuence leptin sig-
naling and metabolic homeostasis.
The LIM domain only 4 (LMO4) protein is a cytoplas-
mic and nuclear cofactor that interacts with several
signaling molecules and transcription factors to regulate
gene expression [12–17]. It also interacts with Jak and
augments Stat3 signaling in hepatocytes [15]. Our own
work showed that LMO4 also contributes to Stat3 activa-
tion in neurons [12, 14]. Importantly, LMO4 is expressed
in selected nuclei of the hypothalamus, including the VMH
and PVN [18]. Thus, given its function in Jak/Stat3 sig-
naling, we asked whether LMO4 contributes to central
leptin control of metabolic homeostasis.
LMO4 is expressed in the central nervous system early
during embryonic development [13] and germline ablation
of LMO4 is lethal prior to birth [19]. To circumvent this
problem, we created mice in which LMO4 is selectively
ablated in postmitotic glutamatergic neurons after birth.
Since the majority of neurons of the VMH and PVN of the
hypothalamus are glutamatergic [20, 21] and glutamatergic
efferents from these two nuclei are important in regulating
feeding and autonomic and neuroendocrine functions [5,
22, 23], these mice enabled us to address the importance of
LMO4 in leptin signaling and hypothalamic control of
metabolism.
Materials and methods
Animal care
All procedures were approved by the animal care and use
committee of the University of Ottawa. Animals were bred
and maintained under a 12 h light and 12 h dark
(1800–0600) cycle. Food (regular chow) and water were
provided ad libitum unless speciﬁed.
Generation of CamK2aCre/LMO4ﬂox mice
CamK2aCre/LMO4ﬂox and LMO4ﬂox littermate mice
were genotyped and maintained on a CD-1 background as
described [16].
Food intake
Mice were transferred to individual housing and habituated
for 1 week. Daytime and nighttime food intake was
calculated by averaging the food intake of each mouse over
the 3 day experimental period.
MRI
Six-month-old littermate male mice anesthetized by i.p.
injection of ketamine/xylazine/acepromazine were scanned
in pairs, and the images were acquired using a multi-
channel wrist coil adapted to the 3T GE MRI scanner.
Acute and chronic intracerebroventricular (icv) leptin
infusion
Two-month-old male mice were anesthetized. For acute
perfusion, 1 lg/ll recombinant mouse leptin (Invitrogen,
Cat #PMP0013) in sterile saline was stereotaxically infused
(0.25 ll/min). For chronic infusion, an Alzet osmotic pump
(Alzet, CA, USA; 1007D) was implanted subcutaneously
and 10 lg leptin was infused (0.5 ll/h) over 7 days.
Leptin ELISA
Blood samples were collected between 1400 and 1600 h
for plasma leptin determination using a mouse Leptin (Cat.
# 90030) ELISA kit (Crystal Chem, IL, USA).
Norepinephrine turnover rate (NETO)
Eight-week-old male mice received two intraperitoneal
injections of DL-a-methyl-p-tyrosine (sigma) at time 0
(250 mg/kg, 25 mg/ml) and 2 h (125 mg/kg, 2.5 mg/ml).
At 4 h time, tissues were harvested and NETO was deter-
mined as described [24].
Indirect calorimetry
Mice were single-housed in metabolic chambers, oxygen
consumption (VO2) and carbon dioxide production (VCO2)
were measured for 24 h using an Oxymax system with
automatic temperature and light controls (Columbus
Instruments, Columbus, OH). Temperature was maintained
at 24C with 12 h light/dark cycle.
Quantitative real-time RT-PCR (qPCR)
Total RNA from hypothalamus was extracted for qPCR
using Taq DNA polymerase/cyber green PCR mix. All
mRNA levels were normalized to actin. qPCR primers used
included: LMO4: 50-GGACCGCTTTCTGCTCTATG-30
50-AAGCACCGCTATTCCCAAAT-30; ACC: 50-AGCAG
ATCCGCAGCTTGGT-30 50-ACTTCTGCTCGCTGGGT
GG-30; FAS: 50-GCTGGCATTCGTGATGGAGTCGT-30
50-AGGCCACCAGTGATGATGTAACTCT-30; Hsl: 50-G
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123ACTCACCGCTGACTTCCT-30 50-CTGTCTCGTTGCGT
TTGTAG-30; Atgl: 50-TGGGTGACCATCTACCTTCC-30
50-CCCAGTGAGAGGTTGTTTCG-30; actin: 50-GCTTCT
TTGCAGCTCCTTCG-30 50-CCTTCTGACCCATTCCCA
CC-30; FAAH: 50-ATGTGGATAGCCTGGCATTGTG-30
50-CTGGAGTGGGCATGGTGTAGTT-30; UCP1: 50-AAA
GTCCGCCTTCAGATC-30 50-AGTTTCGGCAATCTTCT-30.
In situ hybridization, immunoﬂuorescence, and western
blot
In situ hybridization was performed as described [25]
using 300 nucleotides of DIG-UTP-labeled LMO4 exon 2
anti-sense RNA probes. For pStat3 immunoﬂuorescence,
anti-phosphorylated Tyr705-Stat3 primary antibody (cell
signaling technologies) were incubated for 48 h at 4C
and detected with biotin-conjugated secondary antibody
followed by cy3-conjugated streptavidin. Western immu-
noblots were performed as described [16] using actin
(sigma), Akt, and phosphorylated Ser473-Akt antibodies
(cell signaling technologies).
Thermogenesis study
For cold challenge, mice were fasted 16 h and housed
individually, without food and a minimum amount of cage
bedding at 4C for 4 h. Rectal temperature was measured.
For non-shivering thermogenesis, mice at room tempera-
ture were anesthetized using a ketamine/xylazine, and
rectal core temperature was measured.
Statistical analysis
All results are expressed as mean ± SEM and analyzed
using Statistical Package for the Social Sciences (SPSS).
For between group comparisons, a two-tailed unpaired
Student’s t test was used. Where appropriate, data were
analyzed by ANOVA followed by LSD post hoc test to
compare means between groups. P values of\0.05 were
considered signiﬁcant.
Results
Neuron-targeted ablation of LMO4 causes adult onset
obesity
LMO4 is expressed in the cortex, hippocampus, and hypo-
thalamic nuclei including the PVN and VMH, but not the
ARC (Fig. 1a–c). Although our model (Camk2aCre/
LMO4ﬂox)doesnotspeciﬁcallytargethypothalamicnuclei,
the use of a Cre-transgene activated in the ﬁrst post-natal
week inglutamatergicneuronsenabled ablationofLMO4in
the majority of neurons in the PVN and VMH [20, 21]a s
shown by in situ hybridization (Fig. 1d). We further con-
ﬁrmed that ablation of LMO4 was neural-speciﬁc by PCR
ampliﬁcation of genomic DNA extracted from various tis-
sues (Fig. 1e). qPCR ofhypothalamic RNA extracts showed
a 90% reduction in LMO4 mRNA (Fig. 1f). The overt
phenotype of this ablation was adult onset obesity (Fig. 1g).
Male CamK2aCre/LMO4ﬂox mice fed regular chow start-
ing at 3 weeks of age at the time of weaning developed
signiﬁcant obesity between 3 and 4 months of age (Fig. 1h).
Disregulated fat metabolism in CamK2aCre/LMO4ﬂox
mice
Even though at 2 months of age there was no signiﬁcant
difference in body weights between CamK2aCre/LMO4-
ﬂox mice and littermate controls, excess fat stores
(adiposity) were detected (Fig. 2a). There was nearly twice
the amount of gonadal white adipose tissue (gWAT) and
interscapular brown adipose tissue (BAT) in mutant mice
at 2 and 4 months of age (Fig. 2a, b). MRI scans showed
the increased prevalence of visceral and subcutaneous
adiposity at 4 months (Fig. 2c). qPCR revealed dysregu-
lated lipogenic and lipolytic gene expression in white
adipose tissue and liver of the mutant mice as early as
1 month of age (Fig. 2d, e). Increased lipid droplet deposits
were prevalent in WAT and BAT at 4 months (Fig. 2f).
Surprisingly, even though mutant mice had increased
adiposity at 2 months of age, which would predict elevated
leptin secretion, their plasma leptin levels were similar to
littermate controls (Fig. 2g), and importantly, they were not
hyperphagic at this age (Fig. 2h). To account for adiposity,
the energy expenditure was compared at 2 months of age.
Voluntary locomotor activity monitored by beam break was
not different (Fig. 2i). However, whole-body oxygen con-
sumption (VO2) measured by indirect calorimetry and
adjusted to lean body mass [26] at 2 months was lower
during the light phase in mutant mice (Fig. 2j), indicating
reduced energy expenditure. No difference in fuel type
utilization as determined by respiratory exchange rate
(RER) was detected (Fig. 2k). By 4 months LMO4 mutant
mice became hyperleptinemic (Fig. 2g) and hyperphagic,
with signs of leptin resistance, i.e., the central leptin effect
to suppress feeding behavior was lost and food intake was
elevated by 50% (Fig. 2h). Reduced energy expenditure,
together with the late-onset hyperphagia, likely contribute
to the marked weight gain seen at this stage (Fig. 1h).
Reduced sympathetic tone to adipose tissue in LMO4
mutant mice
Sympathetic neural activity is important to control fat
metabolism, energy homeostasis, and heat production
Hypothalamic LMO4 regulates fat metabolism 821
123among other physiological processes [8, 27, 28]. To deter-
mine whether reduced metabolic activity and adiposity
observed at the age of 2 months when food intake was not
increased were associated with reduced sympathetic activ-
ity, we used two approaches to measure sympathetic
activity. First, we measured body temperature in response to
cold challenge as an index of sympathetic activity to BAT.
Cold challenge is known to increase sympathetic activity to
augment heat production and maintain body temperature
[27]. We observed impaired thermogenesis in CamK2aCre/
LMO4ﬂox mice when core temperatures was measured in
conscious mice exposed to 4C for 4 h (shivering and
nonshivering BAT thermogenesis, Fig. 3a) or in anesthe-
tized mice at room temperature (nonshivering BAT
thermogenesis, Fig. 3b). In line with these observations,
basal levels of thermogenic mitochondrial uncoupling
protein 1 (UCP1) mRNA were reduced in BAT of LMO4
mutant mice (Fig. 3c). A second approach to measure
sympathetic activity was the norepinephrine turnover
(NETO) assay; an index of sympathetic activity to periph-
eral tissues that is extrapolated from the rate of decline in
tissue NE content after inhibiting catecholamine synthesis.
The NETO assay revealed a signiﬁcantly lower sympathetic
outﬂow to BAT and gWAT in LMO4 mutant mice com-
pared to littermate controls (Fig. 3d). Together, these
results provide compelling evidence that sympathetic out-
ﬂow to adipose tissues was lower in LMO4 mutant mice.
Central leptin signaling in the VMH is impaired
in LMO4 mutant mice
To test whether hypothalamic leptin signaling is affected
by LMO4 ablation, leptin was injected into the cerebral
ventricles and immunoﬂuorescence was performed to
compare phosphorylation of Stat3 in neurons of the VMH
and ARC at 2 months of age, when endogenous plasma
Fig. 1 Neuron-speciﬁc ablation of LMO4 leads to adult onset
obesity in CamK2aCre/LMO4ﬂox male mice. In situ hybridization of
14 lm cryosections revealed LMO4 mRNA expression in the PVN
(a) and the VMH (a, b), but not in the ARC (b) in littermate control
mice. Low power magniﬁcations revealed LMO4 expression in
cortex, hippocampus, amygdala, and hypothalamus of a littermate
control (c) but not in the CamK2aCre/LMO4ﬂox mouse (d)a t
2 months of age. Scale bars 200 lm( a, b) and 400 lm( c, d). e PCR
ampliﬁcation across the ﬂoxed exon 2 of LMO4 of genomic DNA
from various tissues from CamK2aCre/LMO4ﬂox mice at weaning
reveals selective ablation of LMO4 in neuronal tissues (asterisks).
Diagram shows ampliﬁed unﬂoxed fragment is larger than the ﬂoxed
allele. (WAT White adipose tissue, Thy thyroid, Sto stomach, S.C.
spinal cord, Pan pancreas, Mus muscle, Lun lung, Liv liver, Kid
kidney, S.I. small intestine, L.I. large intestine, Hyt hypothalamus, Hrt
heart, Tes testicle, Ctx cortex, Ceb cerebellum, B.S. brain stem, BAT
brown adipose tissue). f Quantitative RT-PCR from RNA puriﬁed
from the hypothalamus shows a 90% reduction in LMO4 levels
(*p\0.05, n = 6 per group) in CamK2aCre/LMO4ﬂox mice (a.u.
arbitrary units, normalized to littermate control). g Male CamK2aCre/
LMO4ﬂox mice (KO) aged 4 months were obviously obese compared
to littermate controls (WT). h The onset of obesity was signiﬁcant
after 12 weeks (asterisk indicates p\0.05, n C 12 per group). Black
diamonds WT, open diamonds KO
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123Fig. 2 Increased adiposity in CamK2aCre/LMO4ﬂox mice. Gonadal
white adipose tissue (gWAT) weights were increased at 2 months
(a) and 4 months (b) of age in KO mice (n = 6 per group). Brown
adipose tissue (BAT) weights were also increased at 4 months (b).
c MRI revealed extensive adiposity (white) of KO mice compared to
WT littermate at 6 months. Water and oil standards are shown for
comparison (representative scan of three mice per group). qPCR
measured lipogenic (ACC and FAS) and lipolytic (HSL and Atgl)
gene expression in liver (d) and in gonadal WAT (e) at 1 month of
age (n C 4 per group). Signiﬁcantly elevated levels were detected in
gWAT of KO mice. f Parafﬁn sections (6 lm) of WAT and BAT
were stained with hematoxylin and eosin and showed increased lipid
droplet size at 4 months of age. Representative image of three mice
per group; scale bar 100 lm. g Plasma leptin levels were signiﬁcantly
elevated in KO mice at 4 months of age (n = 8–11 mice per group).
h Daytime and nighttime food intake averaged over 3 days was not
different at 2 months but was elevated in 4 month old KO mice
(n = 9–20 mice per group). i Locomotor activity, measured by
autonomic beam break over a 24 h period, was similar between
littermate KO and WT at 4 months of age. Indirect calorimetry
indicates similar metabolic rate between littermate KO and WT at
4 months of age. j Oxygen consumption (VO2) adjusted to lean body
mass and k respiratory exchange rates (VCO2/VO2) were measured
per mouse for 24 h at 2 months of age when the body weight was not
different between WT and KO mice (n C 8 per group). Light phase
VO2 was reduced in KO mice (*p\0.05). Filled bars WT, open bars
KO
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123leptin levels are not different (see Fig. 2g). Markedly fewer
phospho-Stat3-positive neurons were detected in the VMH
of LMO4 mutant mice compared to littermate controls
(Fig. 4a, c, e). In contrast, a similar number of phospho-
Stat3-immunopositive neurons were detected in neurons in
the ARC of littermate control and LMO4 mutant mice
(Fig. 4b, d, e). Very few phospho-Stat3-immunopositive
neurons were detected in the PVN (data not shown), con-
sistent with the paucity of leptin-receptor-positive neurons
in this nucleus [29]. These results show that LMO4 is
required for leptin-induced Stat3 activation in the VMH but
not in the ARC.
Central leptin control of fat metabolism but not feeding
behavior is impaired in LMO4 mutant mice
Hypothalamic leptin signaling causes weight loss by sup-
pressing feeding and promoting lipolysis [8]. Chronic icv
leptin infusion over 7 days (Fig. 5a) at 2 months of age
suppressed feeding to a similar extent in both LMO4
mutant and littermate control mice (Fig. 5b). However,
leptin-induced weight and fat loss were less pronounced in
LMO4 mutant mice (Fig. 5c, d). One of the ways leptin
induces fat loss is by increasing sympathetic outﬂow to
adipose tissue to increase thermogenesis and energy
expenditure. Central leptin infusion upregulated UCP1
mRNA in BAT of littermate control mice but failed to do
so in LMO4 mutant mice (Fig. 5e). Thus, reduced ther-
mogenesis and energy expenditure in LMO4 mutant mice
after chronic leptin infusion would result in less fat loss.
In addition, leptin-induced elevation of sympathetic
activity activates the expression of fatty acid amidohy-
drolase (FAAH) in adipose tissue, and this would also
promote fat loss [8]. FAAH is an enzyme that metabolizes
the endogenous cannabinoid anandamide thereby prevent-
ing anandamide from activating CB1 receptors to promote
lipogenesis [30]. Consequently, elevated FAAH favors
lipolysis [8]. Chronic central leptin infusion increased
FAAH expression in WAT of littermate control but not of
LMO4 mutant mice, as revealed by qPCR (Fig. 5e). In line
with this ﬁnding, expression of the lipogenic genes ACC
and FAS was reduced in WAT of littermate control mice
after leptin infusion, but not in LMO4 mutant mice
(Fig. 5e). Taken together, these results demonstrate that
LMO4 is important for hypothalamic leptin signaling to
regulate fat metabolism.
Discussion
Our study identiﬁed LMO4 as a modulator of leptin sig-
naling in the hypothalamus. Importantly, LMO4 is
Fig. 3 Reduced sympathetic
tone to adipose tissues in
CamK2aCre/LMO4ﬂox mice.
Reduced thermogenic ability
was observed in 2-month-old
CamK2aCre/LMO4ﬂox male
mice upon cold challenge of
conscious mice at 4C( a)o r
anesthetized mice at room
temperature (b)( n = 6 per
group). c Quantitative RT-PCR
revealed lower levels of
uncoupling protein-1 (UCP1)
mRNA in BAT of cold-
challenged KO mice.
d Norepinephrine turnover
(NETO) assay revealed reduced
sympathetic outﬂow to BAT
and WAT in KO mice at
2 months of age (n = 8 per
group). WT (black diamonds),
KO (open diamonds)
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123expressed in some, but not all, hypothalamic nuclei where
leptin receptors are expressed [29]. We found that LMO4 is
expressed in the VMH but not in the ARC, and consistent
with their predominant effects in regulating fat metabo-
lism/energy expenditure and feeding [31], respectively,
ablation of LMO4 in the VMH caused a primary defect in
the central control of fat metabolism rather than feeding
behavior. This regional-speciﬁc expression pattern of
LMO4 enables selective regulation of physiological activ-
ities that are controlled by hypothalamic leptin signaling.
Several lines of evidence support the requirement for
LMO4 in modulating leptin signaling to control fat
metabolism. First, leptin signaling phosphorylates and
activates Stat3, but in the VMH of Camk2aCre/LMO4ﬂox
mice where LMO4 expression is ablated, leptin induced
fewer phosphorylated-Stat3-immunopositive neurons
compared to littermate control mice. Our ﬁnding that
LMO4 is required for Jak/Stat3 signaling in VMH hypo-
thalamic neurons is consistent with previous studies
demonstrating that LMO4 participates in Jak/Stat3 signal-
ing in hepatocytes [15] and in primary cortical neurons
[14]. In hepatocytes, LMO4 was found to interact with
Jak2, and ablation of LMO4 with siRNA blunted Stat3
phosphorylation and activation in response to IL-6 cyto-
kine stimulation [15]. Thus, LMO4 modulation of Jak/Stat3
signaling is likely to be a general feature in tissues where
LMO4 is expressed, including the VMH.
Second, leptin signaling in the VMH activates sympa-
thetic outﬂow to adipose tissue to promote fat metabolism
by inhibiting lipogenesis and increasing energy expendi-
ture [7, 8, 32, 33]. Consistent with reduced leptin signaling
in the VMH, sympathetic outﬂow to the WAT and BAT
was signiﬁcantly lower in LMO4 mutant mice. As early as
1 month, there was a tenfold higher expression of lipo-
genesis genes in WAT of LMO4 mutant mice. In the
mutant mice, the BAT thermogenic response to cold
challenge was impaired, the expression of thermogenic
mitochondrial uncoupling protein UCP1 was lower and fat
droplets were larger in BAT, indicative of reduced fat
combustion. The consequent impaired thermogenic
response and reduced oxygen consumption would result in
an energy surplus and increased fat stores. Indeed,
increased adiposity was observed at 2 months, when no
increase in food intake was detected. Thus, impaired cen-
tral leptin signaling and consequently lower sympathetic
outﬂow likely account for the early appearance of adiposity
in LMO4 mutant mice.
Third, fat loss induced by chronic central leptin infusion
was impaired in LMO4 mutant mice. The anorexic
response to central leptin administration, on the other hand,
was relatively unaffected in LMO4 mutant mice. Unlike in
the VMH, leptin induced a similar number of phospho-
Stat3-positive neurons in the ARC, a key hypothalamic
nucleus for feeding control. This result was not surprising
since LMO4 is not expressed in the ARC. Taken together,
these results highlight that the involvement of LMO4 in
leptin-regulated neuroendocrine activities is highly selec-
tive, i.e. affecting fat metabolism rather than feeding
suppression.
The phenotype of early increased adiposity without
increased food intake observed in LMO4 mutant mice is
reminiscent of mice with leptin receptors ablated in VMH
neurons (SF1-Cre/Leprﬂox) [7, 34]. In these SF1-Cre/
Leprﬂox mice, a signiﬁcant expansion of both white and
brown adipose compartments was noted, even when their
weight and food intake [7] did not differ from WT mice,
suggesting a defect in energy partitioning preferentially
directing calories into fat rather than lean body mass [34].
Fig. 4 Selective reduction in central leptin signaling in CamK2aCre/
LMO4ﬂox mice. Immunoﬂuorescence staining of phospho-Stat3
60 min after acute intracerebroventricular leptin injection revealed
markedly reduced response in KO mice at the VMH, but a similar
response in the ARC. a, b WT and c, d KO at 2 months of age. ARC
Arcuate nucleus, VMH ventromedial hypothalamus. Scale bar
100 lm. Representative sections from leptin-injected mice are shown
to illustrate different regions of the hypothalamus. e Quantiﬁcation of
pStat3-positive cells in different hypothalamic nuclei per section.
Cells from both sides of hypothalamic nuclei between Bregma -1.6
and -1.8 mm were counted and averaged. Cells per section were
counted for three to ﬁve sections from each mouse. n = 3 per group.
Filled bars WT, open bars KO. *p\0.05
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123However, adiposity in our mice becomes more pronounced
than in SF-1Cre/Leprﬂox mice. Several factors are likely to
contribute to this phenotype. First, early reduced energy
expenditure likely accelerates energy surplus and fat
accumulation in our mice. Second, LMO4 ablation in other
brain regions in addition to the VMH, for example the
PVN, is likely to worsen the obesity phenotype in our mice.
Although few neurons in the PVN express leptin receptors
[29], the PVN is a relay point receiving synaptic inputs
from multiple hypothalamic nuclei to regulate energy
expenditure and satiety [29, 35] and the PVN regulates
sympathetic outﬂow to BAT and WAT [36]. In addition,
the PVN contains neurons producing important neuropep-
tides such as oxytocin, corticotropin releasing hormone,
and thyrotropin releasing hormone that play an important
role in regulating food intake and energy expenditure [37–
39]. Future studies will be needed to know which neuro-
peptides are expressed in LMO4-positive neurons of the
PVN and how ablation of LMO4 in this nucleus affects
metabolism. Impaired signaling through the PVN could
also contribute to adiposity in the Camk2aCre/LMO4ﬂox
mice. Although outside the scope of the present study, the
consequence of LMO4 ablation on synaptic transmission in
the PVN may reveal additional mechanisms contributing to
the metabolic defect in LMO4 mutant mice.
The onset of weight gain occurs much later in Cam-
k2aCre/LMO4ﬂox mice (around 12 weeks) compared to
two similar mouse models that disrupt leptin signaling,
Camk2aCre/LepRﬂox [40] and CamK2aCre/Shp2ﬂox [41]
mice, where the obesity phenotype is manifest at
5–6 weeks of age. We reasoned that early disruption of
leptin signaling in the ARC in addition to other
Fig. 5 Effects of chronic leptin
infusion. a Diagram of the
chronic icv leptin infusion
protocol using an osmotic
minipump in 2-month-old mice.
Body weight changes were
measured daily, and food intake
was measured from day 4 to day
7( n = 6–8 per group). b Leptin
infusion suppressed food intake
in both littermate control and
KO mice. c Leptin-induced
weight loss was not as great in
KO mice as in WT mice
(*p\0.05). Black diamonds
WT, open diamonds KO.
d Leptin induced a 50% gonadal
WAT (gWAT) weight loss in
WT but not in KO mice.
e Quantitative RT-PCR showed
that leptin reduced lipogenic
gene expression and activated
the cannabinoid metabolizing
enzyme FAAH in WAT of WT
but not in KO mice. Similarly,
leptin increased UCP1 mRNA
expression in BAT in WT but
not in KO mice
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123hypothalamic nuclei might account for the earlier weight
gain in these two mouse models. As CamK2aCre transgene
is expressed in the ARC, leptin signaling is disrupted in the
ARC of Camk2aCre/LepRﬂox [40] and CamK2aCre/
Shp2ﬂox [41] mice early after birth. In contrast, because
LMO4 is not expressed in the ARC, leptin signaling
remains intact in the ARC of LMO4 mutant mice at least at
2 months of age. As adiposity progresses in the LMO4
mutant mice, they become hyperleptinemic and hyper-
phagic at 4 months of age, indicating that the response to
leptin in the ARC becomes defective. It is well-established
that hyperleptinemia is associated with hyperphagia and
impaired leptin signaling in the ARC [42]. Hyperphagia
would contribute to the accelerated weight gain observed at
4 months of age in LMO4 mutant mice.
Our ﬁndings are likely to be relevant to human obesity.
Functional promoter polymorphisms that affect the level of
LMO4 expression have been described [43]. Thus, differ-
ences in LMO4 expression in hypothalamic neurons might
affect leptin signaling and susceptibility to obesity. In
addition, LMO4 expression in the brain is dynamically
regulated under different physiological conditions: it ﬂuc-
tuates with a circadian rhythm in the suprachiasmatic
nucleus of the hypothalamus [44]; it responds to hyper- and
hypo-osmotic stresses in the supraoptic nucleus of the
hypothalamus [45], to sleep deprivation in the cerebral
cortex [46], and to ischemic stress in striatal and cortical
neurons [16]. Future studies will need to address whether
physiological stresses inﬂuence fat metabolism by altering
central LMO4 expression.
In summary, we present a novel mouse model of early
onset adiposity progressing to adult obesity. Our study
showed that LMO4 is a novel and regional-speciﬁc mod-
ulator of leptin signaling that enables selective leptin
actions to control fat metabolism.
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